AAAAAA

   
Results: 1-25 | 26-42
Results: 1-25/42
HIGH EXPRESSION OF BCL-2 MESSENGER-RNA AS A DETERMINANT OF POOR-PROGNOSIS IN ACUTE MYELOID-LEUKEMIA
Authors: KARAKAS T MAURER U WEIDMANN E MIETHING CC HOELZER D BERGMANN L
Citation: T. Karakas et al., HIGH EXPRESSION OF BCL-2 MESSENGER-RNA AS A DETERMINANT OF POOR-PROGNOSIS IN ACUTE MYELOID-LEUKEMIA, Annals of oncology, 9(2), 1998, pp. 159-165
ESTABLISHMENT OF DENDRITIC CELLS USING PERIPHERAL MONOCYTES FROM PATIENTS WITH AML IN COMPLETE REMISSION FOLLOWING CHEMOTHERAPY
Authors: WEIDMANN E SCHUI DK SINGH L HOELZER D
Citation: E. Weidmann et al., ESTABLISHMENT OF DENDRITIC CELLS USING PERIPHERAL MONOCYTES FROM PATIENTS WITH AML IN COMPLETE REMISSION FOLLOWING CHEMOTHERAPY, Journal of leukocyte biology, 1998, pp. 17-17
BASIC REQUIREMENTS FOR THE USE OF TERMS FOR REPORTING ADVERSE DRUG-REACTIONS .8. RENAL AND URINARY SYSTEM DISORDERS
Authors: AELLIG W BANKOWSKI Z BAUMBAUER E BRUPPACHER R CONE M COVESMITH R DEBRE M EDWARDS IR GALLAGHER J GRABENSEE B IDANPAANHEIKKILA J KREMER G KREUTZ G KRUPP P LESKI M LUMPKIN MM OSTER M PFEIFFER M ROCCO F SAUER F SCHOU J SHRANK J SCHUMANN W SPIEGL W SPINELLI F SPRENGER K TENHAM M TRENQUE T VENULET J WEIDMANN E WEISS JM WOOD KL
Citation: W. Aellig et al., BASIC REQUIREMENTS FOR THE USE OF TERMS FOR REPORTING ADVERSE DRUG-REACTIONS .8. RENAL AND URINARY SYSTEM DISORDERS, Pharmacoepidemiology and drug safety, 6(3), 1997, pp. 203-211
WILMS-TUMOR GENE-EXPRESSION IN ACUTE MYELOID LEUKEMIAS
Authors: BERGMANN L MAURER U WEIDMANN E
Citation: L. Bergmann et al., WILMS-TUMOR GENE-EXPRESSION IN ACUTE MYELOID LEUKEMIAS, Leukemia & lymphoma, 25(5-6), 1997, pp. 435-443
ESTABLISHMENT AND CHARACTERIZATION OF A NEW, FACTOR-INDEPENDENT ACUTEMYELOID-LEUKEMIA LINE DESIGNATED EI501
Authors: WEIDMANN E BRIEGER J KARAKAS T MAURER U PASCHEBERG U HOELZER D MITROU PS BERGMANN L
Citation: E. Weidmann et al., ESTABLISHMENT AND CHARACTERIZATION OF A NEW, FACTOR-INDEPENDENT ACUTEMYELOID-LEUKEMIA LINE DESIGNATED EI501, Leukemia, 11(5), 1997, pp. 709-713
THE WILMS-TUMOR GENE IS EXPRESSED IN A SUBSET OF CD34(-REGULATED EARLY IN THE COURSE OF DIFFERENTIATION IN-VITRO() PROGENITORS AND DOWN)
Authors: MAURER U BRIEGER J WEIDMANN E MITROU PS HOELZER D BERGMANN L
Citation: U. Maurer et al., THE WILMS-TUMOR GENE IS EXPRESSED IN A SUBSET OF CD34(-REGULATED EARLY IN THE COURSE OF DIFFERENTIATION IN-VITRO() PROGENITORS AND DOWN), Experimental hematology, 25(9), 1997, pp. 945-950
HIGH-LEVELS OF WILMS-TUMOR GENE (WT1) MESSENGER-RNA IN ACUTE MYELOID LEUKEMIAS ARE ASSOCIATED WITH A WORSE LONG-TERM OUTCOME
Authors: BERGMANN L MIETHING C MAURER U BRIEGER J KARAKAS T WEIDMANN E HOELZER D
Citation: L. Bergmann et al., HIGH-LEVELS OF WILMS-TUMOR GENE (WT1) MESSENGER-RNA IN ACUTE MYELOID LEUKEMIAS ARE ASSOCIATED WITH A WORSE LONG-TERM OUTCOME, Blood, 90(3), 1997, pp. 1217-1225
CONSTITUTIVE EXPRESSION OF WILMS-TUMOR GENE IN K562 DOES NOT ALTER TPA-INDUCED DIFFERENTIATION
Authors: MAURER U WEIDMANN E KRAPOHL A SCHNEIDER B KARAKAS T HOELZER D BERGMANN L
Citation: U. Maurer et al., CONSTITUTIVE EXPRESSION OF WILMS-TUMOR GENE IN K562 DOES NOT ALTER TPA-INDUCED DIFFERENTIATION, Blood, 90(10), 1997, pp. 3775-3775
HIGH EXPRESSION OF BCL-2 MESSENGER-RNA AS A DETERMINANT OF POOR-PROGNOSIS IN ACUTE MYELOID-LEUKEMIA
Authors: KARAKAS T MAURER U WEIDMANN E HOELZER D BERGMANN L
Citation: T. Karakas et al., HIGH EXPRESSION OF BCL-2 MESSENGER-RNA AS A DETERMINANT OF POOR-PROGNOSIS IN ACUTE MYELOID-LEUKEMIA, Blood, 90(10), 1997, pp. 287-287
THE COEXPRESSION OF BCL-2 AND WT1 MESSENGER-RNA IMPLICATES A NEW PROGNOSTIC SCORE IN ACUTE MYELOID-LEUKEMIA
Authors: BERGMANN L KARAKAS T MIETHING CC MAURER U WEIDMANN E HOELZER D
Citation: L. Bergmann et al., THE COEXPRESSION OF BCL-2 AND WT1 MESSENGER-RNA IMPLICATES A NEW PROGNOSTIC SCORE IN ACUTE MYELOID-LEUKEMIA, Blood, 90(10), 1997, pp. 2497-2497
WILMS-TUMOR GENE (WT1) MESSENGER-RNA IS EQUALLY EXPRESSED IN BLAST CELLS FROM ACUTE MYELOID-LEUKEMIA AND NORMAL CD34(+) PROGENITORS
Authors: MAURER U WEIDMANN E KARAKAS T HOELZER D BERGMANN L
Citation: U. Maurer et al., WILMS-TUMOR GENE (WT1) MESSENGER-RNA IS EQUALLY EXPRESSED IN BLAST CELLS FROM ACUTE MYELOID-LEUKEMIA AND NORMAL CD34(+) PROGENITORS, Blood, 90(10), 1997, pp. 4230-4231
PERIPHERAL T-CELL LYMPHOMAS RESPOND WELL TO VINCRISTINE, ADRIAMYCIN, CYCLOPHOSPHAMIDE, PREDNISONE AND ETOPOSIDE (VACPE) AND HAVE A SIMILAR OUTCOME AS HIGH-GRADE B-CELL LYMPHOMAS
Authors: KARAKAS T BERGMANN L STUTTE HJ JAGER E KNUTH A WEIDMANN E MITROU PS HOELZER D
Citation: T. Karakas et al., PERIPHERAL T-CELL LYMPHOMAS RESPOND WELL TO VINCRISTINE, ADRIAMYCIN, CYCLOPHOSPHAMIDE, PREDNISONE AND ETOPOSIDE (VACPE) AND HAVE A SIMILAR OUTCOME AS HIGH-GRADE B-CELL LYMPHOMAS, Leukemia & lymphoma, 24(1-2), 1996, pp. 121-129
THE COEXPRESSION OF BCL-2 AND WT-1 MESSENGER-RNA IN ACUTE MYELOID-LEUKEMIA PROVIDES A PROGNOSTIC INDEX FOR THE LONG-TERM OUTCOME
Authors: KARAKAS T MIETHING CC MAURER U WEIDMANN E MITROU PS HOELZER D BERGMANN L
Citation: T. Karakas et al., THE COEXPRESSION OF BCL-2 AND WT-1 MESSENGER-RNA IN ACUTE MYELOID-LEUKEMIA PROVIDES A PROGNOSTIC INDEX FOR THE LONG-TERM OUTCOME, Experimental hematology, 24(9), 1996, pp. 551-551
THE WILMS-TUMOR GENE IS EXPRESSED IN A SUBSET OF CD34+ PROGENITORS
Authors: MAURER U WEIDMANN E HOELZER D BERGMANN L
Citation: U. Maurer et al., THE WILMS-TUMOR GENE IS EXPRESSED IN A SUBSET OF CD34+ PROGENITORS, Blood, 88(10), 1996, pp. 3164-3164
WTL MESSENGER-RNA EXPRESSION AS A SIGNIFICANT PROGNOSTIC FACTOR FOR OUTCOME IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA
Authors: MIETHING CC WEIDMANN E MAURER U HOELZER D BERGMANN L
Citation: Cc. Miething et al., WTL MESSENGER-RNA EXPRESSION AS A SIGNIFICANT PROGNOSTIC FACTOR FOR OUTCOME IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA, Blood, 88(10), 1996, pp. 2243-2243
PROGNOSTIC INDEX FOR THE LONG-TERM OUTCOME OF ACUTE MYELOID-LEUKEMIA BASED ON THE COEXPRESSION OF BCL-2 AND WT-1 MESSENGER-RNA
Authors: BERGMANN L KARAKAS T MIETHING CC MAURER U WEIDMANN E HOELZER D
Citation: L. Bergmann et al., PROGNOSTIC INDEX FOR THE LONG-TERM OUTCOME OF ACUTE MYELOID-LEUKEMIA BASED ON THE COEXPRESSION OF BCL-2 AND WT-1 MESSENGER-RNA, Blood, 88(10), 1996, pp. 2527-2527
FREQUENCY AND FUNCTION OF IL-2-RECEPTOR-ALPHA, IL-2-RECEPTOR-BETA ANDIL-2-RECEPTOR-GAMMA CHAINS ON BLAST CELLS FROM ACUTE MYELOCYTIC-LEUKEMIA
Authors: WEIDMANN E BRIEGER J HOELZER D BERGMANN L MITROU PS
Citation: E. Weidmann et al., FREQUENCY AND FUNCTION OF IL-2-RECEPTOR-ALPHA, IL-2-RECEPTOR-BETA ANDIL-2-RECEPTOR-GAMMA CHAINS ON BLAST CELLS FROM ACUTE MYELOCYTIC-LEUKEMIA, European journal of cancer, 31A, 1995, pp. 37-37
IL-4 INDUCED UP-REGULATION OF BCL-2 IN CLL PATIENTS IN-VIVO AND IN-VITRO
Authors: KARAKAS T BRIEGER J WEIDMANN E MITROU PS MELLSTEDT H HOELZER D BERGMANN L
Citation: T. Karakas et al., IL-4 INDUCED UP-REGULATION OF BCL-2 IN CLL PATIENTS IN-VIVO AND IN-VITRO, European journal of cancer, 31A, 1995, pp. 62-62
LACTATE DEHYDROGENASE-RELEASE ASSAY - A RELIABLE, NONRADIOACTIVE TECHNIQUE FOR ANALYSIS OF CYTOTOXIC LYMPHOCYTE-MEDIATED LYTIC ACTIVITY AGAINST BLASTS FROM ACUTE MYELOCYTIC-LEUKEMIA
Authors: WEIDMANN E BRIEGER J JAHN B HOELZER D BERGMANN L MITROU PS
Citation: E. Weidmann et al., LACTATE DEHYDROGENASE-RELEASE ASSAY - A RELIABLE, NONRADIOACTIVE TECHNIQUE FOR ANALYSIS OF CYTOTOXIC LYMPHOCYTE-MEDIATED LYTIC ACTIVITY AGAINST BLASTS FROM ACUTE MYELOCYTIC-LEUKEMIA, Annals of hematology, 70(3), 1995, pp. 153-158
THE WILMS-TUMOR GENE IS FREQUENTLY EXPRESSED IN ACUTE MYELOBLASTIC LEUKEMIAS AND MAY PROVIDE A MARKER FOR RESIDUAL BLAST CELLS DETECTABLE BY PCR
Authors: BRIEGER J WEIDMANN E MAURER U HOELZER D MITROU PS BERGMANN L
Citation: J. Brieger et al., THE WILMS-TUMOR GENE IS FREQUENTLY EXPRESSED IN ACUTE MYELOBLASTIC LEUKEMIAS AND MAY PROVIDE A MARKER FOR RESIDUAL BLAST CELLS DETECTABLE BY PCR, Annals of oncology, 6(8), 1995, pp. 811-816
THE EXPRESSION OF THE WILMS-TUMOR GENE (WT-1) MESSENGER-RNA IN COMPLETE REMISSION OF AML PRECEDES RELAPSE OF THE DISEASE
Authors: BRIEGER J WEIDMANN E MAURER U MITROU PS HOELZER D BERGMANN L
Citation: J. Brieger et al., THE EXPRESSION OF THE WILMS-TUMOR GENE (WT-1) MESSENGER-RNA IN COMPLETE REMISSION OF AML PRECEDES RELAPSE OF THE DISEASE, Experimental hematology, 23(8), 1995, pp. 781-781
GENOMIC IMPRINTING OF WTI IN BLAST CELLS OF PATIENTS WITH ACUTE MYELOCYTIC-LEUKEMIA APPEARS INDEPENDENT OF WTI EXPRESSION LEVEL
Authors: MAURER U WEIDMANN E BRIEGER J MITROU PS HOELZER D BERGMANN L
Citation: U. Maurer et al., GENOMIC IMPRINTING OF WTI IN BLAST CELLS OF PATIENTS WITH ACUTE MYELOCYTIC-LEUKEMIA APPEARS INDEPENDENT OF WTI EXPRESSION LEVEL, Experimental hematology, 23(8), 1995, pp. 782-782
UP-REGULATION OF BCL-2 IN CLL PATIENTS BY IL-4 IN-VIVO AND IN-VITRO
Authors: KARAKAS T BRIEGER J WEIDMANN E MITROU PS MELLSTEDT H HOELZER D BERGMANN L
Citation: T. Karakas et al., UP-REGULATION OF BCL-2 IN CLL PATIENTS BY IL-4 IN-VIVO AND IN-VITRO, Experimental hematology, 23(8), 1995, pp. 933-933
THE INHIBITION OF LYMPHOKINE-ACTIVATED KILLER-CELLS IN ACUTE MYELOBLASTIC-LEUKEMIA IS MEDIATED BY TRANSFORMING GROWTH FACTOR-BETA(1)
Authors: BERGMANN L SCHUI DK BRIEGER J WEIDMANN E MITROU PS HOELZER D
Citation: L. Bergmann et al., THE INHIBITION OF LYMPHOKINE-ACTIVATED KILLER-CELLS IN ACUTE MYELOBLASTIC-LEUKEMIA IS MEDIATED BY TRANSFORMING GROWTH FACTOR-BETA(1), Experimental hematology, 23(14), 1995, pp. 1574-1580
AML BLASTS VARIABLY EXPRESS INTERLEUKIN-2 RECEPTOR-ALPHA-CHAINS, BETA-CHAINS OR GAMMA-CHAINS WITHOUT MEASURABLE EFFECTS ON PROLIFERATION, CYTOKINE MESSAGE EXPRESSION OR SURFACE EXPRESSION OF ADHESION MOLECULESUPON STIMULATION WITH INTERLEUKIN-2
Authors: WEIDMANN E BRIEGER J BERGMANN L HOELZER D MITROU PS
Citation: E. Weidmann et al., AML BLASTS VARIABLY EXPRESS INTERLEUKIN-2 RECEPTOR-ALPHA-CHAINS, BETA-CHAINS OR GAMMA-CHAINS WITHOUT MEASURABLE EFFECTS ON PROLIFERATION, CYTOKINE MESSAGE EXPRESSION OR SURFACE EXPRESSION OF ADHESION MOLECULESUPON STIMULATION WITH INTERLEUKIN-2, Leukemia research, 19(7), 1995, pp. 469-476
Risultati: 1-25 | 26-42